Clinical studies recruiting near Fresno

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Community Regional Medical Center · Pfizer · NCT05020236 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Kaiser Permanente Fresno Orchard Plaza · National Cancer Institute (NCI) · NCT05564390 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07105111 Post-Market Study to Assess iTind Safety in Comparison to UroLift
NA · Urology Associates of Central California · Olympus Corporation of the Americas · NCT04757116 A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · Research Site 138 · Locus Biosciences · NCT05488340 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Fresno Cancer Center · NRG Oncology · NCT05946213 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · The Nephrology Group, Inc. - Fresno · Biogen · NCT06962800 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente Fresno Orchard Plaza · NRG Oncology · NCT05174169 Persona Revision Knee System Outcomes
Phase N/A · Community Foundation Medical Group · Zimmer Biomet · NCT04821154 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Fresno Cancer Center · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Kaiser Permanente Fresno Orchard Plaza · Alliance for Clinical Trials in Oncology · NCT06931340 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Kura Oncology, Inc. · NCT07007312 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Kaiser Permanente Fresno Orchard Plaza · Alliance for Clinical Trials in Oncology · NCT06876714 Dental Block for Pain Relief in ED Dental Pain Patients
Phase N/A · Community Regional Trauma and Burn Center · University of California, San Francisco · NCT05351099 Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Phase 2 · Urology Associates of Central California Medical Group · Dendreon · NCT06134232 A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · Clinical Research of Central California · Pfizer · NCT07629440 JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid T
Phase 1 · California Cancer Associates for Research and Excellence · Jazz Pharmaceuticals · NCT06108050 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente Fresno Orchard Plaza · NRG Oncology · NCT06748222 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Kaiser Permanente Fresno Orchard Plaza · National Cancer Institute (NCI) · NCT06498635 A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
Phase 2 · Sierra Pacific Arthritis and Rheumatology Centers · Zenas BioPharma (USA), LLC · NCT06559163 MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
Phase 2 · Site 03 · Merakris Therapeutics · NCT04647240 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · California Cancer Associates for Research & Excellence ( Sit · Merck Sharp & Dohme LLC · NCT03486873 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Fresno Cancer Center · NRG Oncology · NCT04852887 A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSm
NA · Costanzo Orthodontics · Dentsply Sirona Implants and Consumables · NCT07290790 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Fresno Cancer Center · Alliance for Clinical Trials in Oncology · NCT05677490 Tissue Repair Gel in Venous Leg Ulcers (US)
Phase 3 · Clincial Research Site 14 · TR Therapeutics · NCT06707090 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Janssen Research & Development, LLC · NCT05552222 RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated
Phase 2 · Altimmune Clinical Study Site · Altimmune, Inc. · NCT07009860 Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers
NA · Limb Preservaion Platform, Inc. · LifeNet Health · NCT07116876

Look up another city

Look up another condition